Free Trial

Maravai LifeSciences (MRVI) Competitors

Maravai LifeSciences logo
$3.41 -0.07 (-2.01%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$3.41 0.00 (0.00%)
As of 10/24/2025 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MRVI vs. AAPG, XENE, QURE, ZLAB, CGON, RARE, IRON, AMRX, APLS, and CNTA

Should you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include Ascentage Pharma Group International (AAPG), Xenon Pharmaceuticals (XENE), uniQure (QURE), Zai Lab (ZLAB), CG Oncology (CGON), Ultragenyx Pharmaceutical (RARE), Disc Medicine (IRON), AMNEAL PHARMACEUTICALS (AMRX), Apellis Pharmaceuticals (APLS), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "pharmaceutical products" industry.

Maravai LifeSciences vs. Its Competitors

Maravai LifeSciences (NASDAQ:MRVI) and Ascentage Pharma Group International (NASDAQ:AAPG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

50.3% of Maravai LifeSciences shares are held by institutional investors. 2.1% of Maravai LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ascentage Pharma Group International has lower revenue, but higher earnings than Maravai LifeSciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maravai LifeSciences$259.18M3.36-$144.85M-$1.36-2.51
Ascentage Pharma Group International$134.35M24.59-$55.54MN/AN/A

In the previous week, Maravai LifeSciences had 1 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 2 mentions for Maravai LifeSciences and 1 mentions for Ascentage Pharma Group International. Ascentage Pharma Group International's average media sentiment score of 1.89 beat Maravai LifeSciences' score of 1.15 indicating that Ascentage Pharma Group International is being referred to more favorably in the news media.

Company Overall Sentiment
Maravai LifeSciences Positive
Ascentage Pharma Group International Very Positive

Ascentage Pharma Group International has a net margin of 0.00% compared to Maravai LifeSciences' net margin of -90.03%. Ascentage Pharma Group International's return on equity of 0.00% beat Maravai LifeSciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Maravai LifeSciences-90.03% -17.60% -9.30%
Ascentage Pharma Group International N/A N/A N/A

Maravai LifeSciences presently has a consensus price target of $5.22, suggesting a potential upside of 53.04%. Given Maravai LifeSciences' higher probable upside, research analysts plainly believe Maravai LifeSciences is more favorable than Ascentage Pharma Group International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maravai LifeSciences
2 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Ascentage Pharma Group International
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Ascentage Pharma Group International beats Maravai LifeSciences on 7 of the 13 factors compared between the two stocks.

Get Maravai LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRVI vs. The Competition

MetricMaravai LifeSciencesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$888.66M$11.01B$6.24B$10.66B
Dividend YieldN/A1.88%5.71%4.82%
P/E Ratio-2.5121.2330.4630.37
Price / Sales3.3630.94595.13134.23
Price / Cash5.6324.9837.0161.44
Price / Book1.503.5012.046.60
Net Income-$144.85M$210.63M$3.32B$276.82M
7 Day Performance3.33%0.74%1.88%2.53%
1 Month Performance26.77%3.10%7.68%3.71%
1 Year Performance-51.42%-7.75%56.01%33.82%

Maravai LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRVI
Maravai LifeSciences
3.8663 of 5 stars
$3.41
-2.0%
$5.22
+53.0%
-52.2%$888.66M$259.18M-2.51610
AAPG
Ascentage Pharma Group International
N/A$35.31
-0.4%
N/AN/A$3.30B$134.35M0.00600Positive News
XENE
Xenon Pharmaceuticals
2.5189 of 5 stars
$43.44
+4.3%
$53.67
+23.5%
-2.6%$3.21B$9.43M-12.24210
QURE
uniQure
2.7984 of 5 stars
$63.92
+10.2%
$71.75
+12.2%
+841.5%$3.18B$27.12M-16.31500Analyst Forecast
Gap Up
ZLAB
Zai Lab
2.7361 of 5 stars
$28.74
+1.6%
$56.35
+96.1%
-20.7%$3.16B$398.99M-14.091,869News Coverage
Analyst Forecast
Analyst Revision
CGON
CG Oncology
2.1114 of 5 stars
$43.59
+5.1%
$58.82
+34.9%
+19.8%$3.16B$1.14M-24.6361Analyst Forecast
RARE
Ultragenyx Pharmaceutical
4.3829 of 5 stars
$34.40
+5.4%
$81.50
+136.9%
-38.8%$3.15B$560.23M-6.221,294News Coverage
Analyst Forecast
Gap Up
IRON
Disc Medicine
2.8374 of 5 stars
$87.17
-3.1%
$108.73
+24.7%
+86.2%$3.13BN/A-19.5030Trending News
Analyst Forecast
Analyst Revision
High Trading Volume
AMRX
AMNEAL PHARMACEUTICALS
2.4049 of 5 stars
$10.24
+3.2%
$12.00
+17.2%
+27.0%$3.12B$2.79B1,025.038,100Analyst Forecast
APLS
Apellis Pharmaceuticals
4.0866 of 5 stars
$27.07
+10.4%
$33.47
+23.6%
+2.1%$3.10B$781.37M-14.87770News Coverage
Upcoming Earnings
Analyst Forecast
Insider Trade
Gap Up
CNTA
Centessa Pharmaceuticals
3.3915 of 5 stars
$22.79
-1.0%
$32.38
+42.1%
+55.8%$3.08B$6.85M-12.73200News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:MRVI) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners